Comparative Bioavailability of TNX-102 and Cyclobenzaprine and Effect of Food on the Pharmacokinetics of TNX-102 in Healthy Adults

Condition:   HealthyInterventions:   Drug: TNX-102 2.4 mg, Fasting conditions;   Drug: TNX-102 2.4 mg, Fed conditions;   Drug: Cyclobenzaprine 5 mg, Fasting conditionsSponsor:   Tonix Pharmaceuticals, Inc.Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials